A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

Thanks to improved therapies, 85% of U.S. children diagnosed with cancer now survive at least five years, with more than half ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, ...

Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date ...

The Food and Drug Administration is weighing whether to allow new advertising messages about Zyn, a type of nicotine pouch ...

Researchers conducted a systematic review of studies assessing the cost-effectiveness or cost-utility of adjuvant immunotherapy for treating various types of cancer.

The U.S. Food and Drug Administration (FDA) has accepted a new drug application for gedatolisib in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA ...

Beware of products claiming to cure cancer on websites or social media platforms, such as Facebook and Instagram. According ...

After seeing Abby Ellis' urgent Sundance documentary "The Lake," on the imminent collapse of Utah's Great Salt Lake due to ...

Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review ...